Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - topiramate 25mg;  ;   - capsule - 25 mg - active: topiramate 25mg     excipient: cellulose acetate gelatin opacode black s-1-17822 opacode black s-1-17823 povidone sucrose - topamax is indicated in adults and children, 2 years and over: · as monotherapy in patients with newly diagnosed epilepsy · for conversion to monotherapy in patients with epilepsy · as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome.

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - topiramate 50mg;  ;   - capsule - 50 mg - active: topiramate 50mg     excipient: cellulose acetate gelatin opacode black s-1-17822 opacode black s-1-17823 povidone sucrose - topamax is indicated in adults and children, 2 years and over: · as monotherapy in patients with newly diagnosed epilepsy · for conversion to monotherapy in patients with epilepsy · as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - metoprolol succinate, quantity: 47.501 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; ethylcellulose; sodium stearylfumarate; triethyl citrate; croscarmellose sodium; purified talc; macrogol 6000; silicified microcrystalline cellulose; silicon dioxide; methacrylic acid copolymer; povidone; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - metoprolol succinate, quantity: 190 mg - tablet, modified release - excipient ingredients: povidone; methacrylic acid copolymer; croscarmellose sodium; ethylcellulose; purified talc; sodium stearylfumarate; microcrystalline cellulose; macrogol 6000; triethyl citrate; silicified microcrystalline cellulose; silicon dioxide; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - metoprolol succinate, quantity: 95 mg - tablet, modified release - excipient ingredients: povidone; triethyl citrate; croscarmellose sodium; methacrylic acid copolymer; purified talc; ethylcellulose; microcrystalline cellulose; silicified microcrystalline cellulose; sodium stearylfumarate; silicon dioxide; macrogol 6000; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - metoprolol succinate, quantity: 23.75 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; ethylcellulose; triethyl citrate; silicified microcrystalline cellulose; methacrylic acid copolymer; sodium stearylfumarate; macrogol 6000; povidone; purified talc; croscarmellose sodium; silicon dioxide; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - metoprolol succinate, quantity: 47.501 mg - tablet, modified release - excipient ingredients: triethyl citrate; sodium stearylfumarate; povidone; silicified microcrystalline cellulose; croscarmellose sodium; ethylcellulose; microcrystalline cellulose; purified talc; methacrylic acid copolymer; silicon dioxide; macrogol 6000; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - metoprolol succinate, quantity: 47.5 mg - tablet, modified release - excipient ingredients: silicon dioxide; croscarmellose sodium; methacrylic acid copolymer; povidone; macrogol 6000; microcrystalline cellulose; ethylcellulose; purified talc; silicified microcrystalline cellulose; sodium stearylfumarate; triethyl citrate; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - metoprolol succinate, quantity: 23.75 mg - tablet, modified release - excipient ingredients: macrogol 6000; ethylcellulose; sodium stearylfumarate; silicon dioxide; triethyl citrate; microcrystalline cellulose; purified talc; methacrylic acid copolymer; croscarmellose sodium; povidone; silicified microcrystalline cellulose; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - metoprolol succinate, quantity: 190 mg - tablet, modified release - excipient ingredients: sodium stearylfumarate; silicon dioxide; ethylcellulose; triethyl citrate; methacrylic acid copolymer; povidone; purified talc; macrogol 6000; croscarmellose sodium; silicified microcrystalline cellulose; microcrystalline cellulose; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.